Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FIZ1 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | TMSB15B | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
mRNA | TCERG1L | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | SMIM17 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | AUTS2 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | ATP2B3 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | ZNF124 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |